The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Open accessAbstract
Background Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades. To assess whether this pathway is causally relevant to coronary heart disease, we studied a functional genetic variant known to affect IL6R signalling.Methods In a collaborative meta-analysis, we studied Asp358Ala (rs2228145) in IL6R in relation to a panel of conventional risk factors and inflammation biomarkers in 125,222 participants. We also compared the frequency of Asp358Ala in 51,441 patients with coronary heart disease and in 136,226 controls. To gain insight into possible mechanisms, we assessed Asp358Ala in relation to localised gene expression and to postlipopolysaccharide stimulation of interleukin 6.Findings The minor allele frequency of Asp358Ala was 39%. Asp358Ala was not associated with lipid concentrations, blood pressure, adiposity, dysglycaemia, or smoking (p value for association per minor allele ≥0·04 for each). By contrast, for every copy of 358Ala inherited, mean concentration of IL6R increased by 34·3% (95% CI 30·4-38·2) and of interleukin 6 by 14·6% (10·7-18·4), and mean concentration of C-reactive protein was reduced by 7·5% (5·9-9·1) and of fibrinogen by 1·0% (0·7-1·3). For every copy of 358Ala inherited, risk of coronary heart disease was reduced by 3·4% (1·8-5·0). Asp358Ala was not related to IL6R mRNA levels or interleukin-6 production in monocytes.Interpretation Large-scale human genetic and biomarker data are consistent with a causal association between IL6R-related pathways and coronary heart disease.Funding British Heart Foundation; UK Medical Research Council; UK National Institute of Health Research, Cambridge Biomedical Research Centre; BUPA Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“genetic evidence suggests that IL-6 may be causal for atherosclerotic cardiovascular disease, 24,25”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,389
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162
Population genomics of human gene expression
Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A. S., Bird, C., Beazley, C., Ingle, C., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,153
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Research works printed but not linked: 2
- Lamas, 2011, Mechanisms underlying the generation of soluble IL-6 soluble receptor (sIL-6R) in rheumatoid arthritis: mRNA alternative splicing and proteolytic cleavage as independent contributors, Arthritis Rheum, 63, 383
- Genovese, 2009, Analysis of low-density lipoprotein and adverse events in rheumatoid arthritis patients treated with tocilizumab plus statins: data from five phase III clinical trials, Rheumatology (Oxford), 48, I81
Cited by
Sorted by citations
Items 201–300 of 823
IL-6 Directed Therapy in Transplantation
Miller, C. L., & Madsen, J. C. (2021) · Current Transplantation Reports · doi:10.1007/s40472-021-00331-4 · Cited by 72
Interleukin-6 and Cardiovascular Events in Healthy Adults
Khan, M. S., Talha, K. M., Maqsood, M. H., Rymer, J. A., Borlaug, B. A., Docherty, K. F., Pandey, A., Kahles, F., Čikeš, M., Lam, C. S. P., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101063 · Cited by 69
C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?
Strang, F., & Schunkert, H. (2014) · Mediators of Inflammation · doi:10.1155/2014/757123 · Cited by 72
Clonal hematopoiesis and non-hematologic disorders
Jaiswal, S. (2020) · Blood · doi:10.1182/blood.2019000989 · Cited by 182
The association of child maltreatment and systemic inflammation in adulthood: A systematic review
Kerr, D. M., McDonald, J. J., & Minnis, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0243685 · Cited by 71
Ridker, P. M., Baeres, F. M. M., Hvelplund, A., Engelmann, M. D. M., Hovingh, G. K., Lincoff, A. M., Marx, N., Návar, A. M., Sattar, N. A., Tuttle, K. R., et al. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.4491 · Cited by 71
Mendelian randomisation applied to drug development in cardiovascular disease: a review
Mokry, L. E., Ahmad, O. S., Forgetta, V., Thanassoulis, G., & Richards, J. B. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102438 · Cited by 67
Hepcidin Deficiency Protects Against Atherosclerosis
Malhotra, R. K., Wunderer, F., Barnes, H. J., Bagchi, A., Buswell, M. D., O’Rourke, C., Slocum, C. L., Ledsky, C. D., Peneyra, K. M., Sigurslid, H. H., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.312215 · Cited by 68
The interleukin 6 pathway and atherosclerosis
Scheller, J., & Rose‐John, S. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61246-x · Cited by 68
Interleukin 6 trans-signalling and risk of future cardiovascular events
Ziegler, L., Gajulapuri, A., Frumento, P., Bonomi, A., Wallén, H., Fairé, U. D., Rose‐John, S., & Gigante, B. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy191 · Cited by 67
Farahi, N., Paige, E., Balla, J., Prudence, E., Ferreira, R. C., Southwood, M. R., Appleby, S. L., Bakke, P. S., Gulsvik, A., Litonjua, A. A., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx053 · Cited by 67
Parisinos, C. A., Serghiou, S., Katsoulis, M., George, M. J., Patel, R. S., Hemingway, H., & Hingorani, A. D. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.022 · Cited by 67
Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease
Schumertl, T., Lokau, J., Rose‐John, S., & Garbers, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119143 · Cited by 68
Mendelian randomization as a tool to inform drug development using human genetics
Daghlas, I., & Gill, D. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.5 · Cited by 65
New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis
Mahmoudi, M., Aslani, S., Fadaei, R., & Jamshidi, A. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12999 · Cited by 67
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?
Ridker, P. M. (2013) · Europe PMC (PubMed Central) · Cited by 67
Inflammation modulation and cardiovascular disease prevention
Awan, Z. A., & Genest, J. J. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314529350 · Cited by 65
Antoun, H., Karouni, M., Abitbol, J., Zouiten, O., & Jemt, T. (2017) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12477 · Cited by 65
The Role of Emerging Risk Factors in Cardiovascular Outcomes
Lacey, B., Herrington, W. G., Preiss, D., Lewington, S., & Armitage, J. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0661-2 · Cited by 69
The IL-12 cytokine family in cardiovascular diseases
van der Heijden, T., Bot, I., & Kuiper, J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.10.010 · Cited by 67
Depression as a non-causal variable risk marker in coronary heart disease
Meijer, A., Zuidersma, M., & de Jonge, P. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-130 · Cited by 65
Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth Rates
Paige, E., Clément, M., Lareyre, F., Sweeting, M. J., Raffort, J., Grenier, C., Finigan, A. J., Harrison, J. E., Peters, J. E., Sun, B. B., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002413 · Cited by 64
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
Khambhati, J., Engels, M., Allard‐Ratick, M., Sandesara, P. B., Quyyumi, A. A., & Sperling, L. S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.007 · Cited by 65
Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., Kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., Arinobu, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196368 · Cited by 62
Sivapalasingam, S., Lederer, D. J., Bhore, R., Hajizadeh, N., Criner, G. J., Hosain, R., Mahmood, A., Giannelou, A., Somersan-Karakaya, S., O’Brien, M. P., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac153 · Cited by 62
Cardiovascular risk in rheumatoid arthritis
Soubrier, M., Chamoux, N. B., Tatar, Z., Couderc, M., Dubost, J., & Mathieu, S. (2014) · Joint Bone Spine · doi:10.1016/j.jbspin.2014.01.009 · Cited by 64
Lokau, J., Agthe, M., & Garbers, C. (2016) · Mediators of Inflammation · doi:10.1155/2016/1785021 · Cited by 62
McManus, D. D., Beaulieu, L. M., Mick, E. O., Tanrıverdi, K., Larson, M. G., Keaney, J. F., Benjamin, E. J., & Freedman, J. E. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301112 · Cited by 62
Inflammation, C-Reactive Protein, and Cardiovascular Disease
Ridker, P. M. (2014) · Circulation Research · doi:10.1161/circresaha.114.303215 · Cited by 63
IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis
Wang, J., Platt, A., Upmanyu, R., Germer, S., Lei, G., Rabe, C., Benayed, R., Kenwright, A., Hemmings, A., Martin, M., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003199 · Cited by 59
Kettunen, J., Ritchie, S. C., Anufrieva, O., Lyytikäinen, L., Hernesniemi, J. A., Karhunen, P. J., Kuukasjärvi, P., Laurikka, J. O., Kähönen, M. A. P., Lehtimäki, T. J., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.002234 · Cited by 60
Insight into rheumatological cause and effect through the use of Mendelian randomization
Robinson, P. C., Choi, H. K., Do, R., & Merriman, T. R. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.102 · Cited by 59
Innate Immunity System in Patients With Cardiovascular and Kidney Disease
Zoccali, C., & Mallamaci, F. (2023) · Circulation Research · doi:10.1161/circresaha.122.321749 · Cited by 61
Ritschel, V. N., Seljeflot, I., Arnesen, H., Halvorsen, S., Eritsland, J., Fagerland, M. W., & Andersen, G. Ø. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003014 · Cited by 59
Nürnberg, S., Guerraty, M. A., Wirka, R. C., Rao, H. S., Pjanic, M., Norton, S., Serrano, F., Matic, L. P., Elwyn, S., Pluta, J. B., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008538 · Cited by 59
Niculeț, E., Chioncel, V., Elisei, A. M., Miulescu, M., Buzia, O. D., Nwabudike, L. C., Crăescu, M., Draganescu, M. L., Bujoreanu, F. C., Marinescu, E., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9693 · Cited by 60
Targeting Inflammation to Reduce Residual Cardiovascular Risk
Ajala, O. N., & Everett, B. M. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00883-3 · Cited by 65
Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?
Laakso, M. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0684-4 · Cited by 62
Shantsila, E., Tapp, L. D., Wrigley, B., Pamukçu, B., Apostolakis, S. Z., Montoro‐García, S., & Lip, G. Y. H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.009 · Cited by 59
Yuan, S., Lin, A., He, Q., Burgess, S., & Larsson, S. C. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.03.053 · Cited by 57
“Our fi ndings for IL-6 are in line with those of previous MR studies of the association between a functional variant in the IL6R gene and CAD [12,13].”
Targeting inflammation in CVD: advances and challenges
Moore, K. J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0144-3 · Cited by 57
Inflammageing, a targetable pathway for preventing cardiovascular diseases
Aranda, J. F., Ramírez, C. M., & Mittelbrunn, M. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae240 · Cited by 64
Harhay, M. O., Tracy, R. P., Bagiella, E., Barr, R. G., Pinder, D., Hundley, W. G., Bluemke, D. A., Kronmal, R. A., Lima, J. A. C., & Kawut, S. M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.028 · Cited by 55
Inflammation beyond the Joints: Rheumatoid Arthritis and Cardiovascular Disease.
Urman, A. R., Taklalsingh, N., Sorrento, C., & McFarlane, I. M. (2018) · Europe PMC (PubMed Central) · Cited by 55
The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells
Yousif, A. S., Ronsard, L., Shah, P., Omatsu, T., Sangesland, M., Moreno, T. B., Lam, E. C., Vrbanac, V. D., Balazs, A. B., Reinecker, H., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.12.001 · Cited by 55
Tucker, B., Vaidya, K., Cochran, B. J., & Patel, S. (2021) · Cells · doi:10.3390/cells10061391 · Cited by 61
Burgess, S., & Cronjé, H. T. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100042 · Cited by 57
Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease
Mack, M. C., & Gopal, A. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.003 · Cited by 59
Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
Kibe, S., Yutani, S., Motoyama, S., Nomura, T., Tanaka, N., Kawahara, A., Yamaguchi, T., Matsueda, S., Komatsu, N., Miura, M., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0035 · Cited by 55
Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials
D’Ugo, E., Libby, P., & De Caterina, R. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-03-0246 · Cited by 54
Genetic Markers of Inflammation and Their Role in Cardiovascular Disease
Raman, K., Chong, M., Akhtar-Danesh, G.-G., D’Mello, M. J. J., Hasso, R., Ross, S. A., Xu, F., & Paré, G. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.025 · Cited by 55
Effect of Continuous Positive Airway Pressure on Cardiovascular Biomarkers
y Mar, H. P., Hazen, S. L., Tracy, R. P., Strohl, K. P., Auckley, D. H., Bena, J., Wang, L., Walia, H. K., Patel, S. R., & Mehra, R. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.03.002 · Cited by 54
Genome-wide association study of circulating interleukin 6 levels identifies novel loci
Ahluwalia, T. S., Prins, B. P., Abdollahi, M., Armstrong, N. J., Aslibekyan, S. W., Bain, L., Jefferis, B. J. M. H., Baumert, J., Beekman, M., Ben‐Shlomo, Y., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab023 · Cited by 52
Berger, M., März, W., Niessner, A., Delgado, G., Kleber, M. E., Scharnagl, H., Marx, N., & Schuett, K. A. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14959 · Cited by 53
Genetic Determinants of P Wave Duration and PR Segment
Verweij, N., Leach, I. M., van den Boogaard, M., van Veldhuisen, D. J., Christoffels, V. M., Study, L. C., Hillege, H. L., van Gilst, W. H., Barnett, P., de Boer, R. A., et al. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000373 · Cited by 50
Immune-mediated mechanisms of atherosclerosis and implications for the clinic
Nus, M., & Mallat, Z. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1195686 · Cited by 57
Shah, T., Zabaneh, D., Gaunt, T. R., Swerdlow, D. I., Shah, S. H., Talmud, P. J., Day, I. N. M., Whittaker, J. C., Holmes, M. V., Sofat, R., et al. (2013) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.964254 · Cited by 52
Fani, L., van der Willik, K. D., Bos, D., Leening, M. J. G., Koudstaal, P. J., Rizopoulos, D., Ruiter, R., Stricker, B. H. C., Kavousi, M., Ikram, M. A., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003115 · Cited by 52
Therapeutic targeting of IL-6 trans-signaling
Rose‐John, S. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155577 · Cited by 52
Sándor, B., Nagy, A., Toth, A., Rábai, M., Mezey, B., Csathó, Á., Czuriga, I., Tóth, K., & Szabados, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110751 · Cited by 52
The IL-6-neutralizing sIL-6R/sgp130 buffer system is disturbed in patients with type 2 diabetes.
Aparicio-Siegmund, S., Garbers, Y., Flynn, C. M., Waetzig, G. H., Gouni-Berthold, I., Krone, W., Berthold, H., Laudes, M., Rose-John, S., & Garbers, C. (2019) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00166.2019 · Cited by 45
Plasma IL-5 concentration and subclinical carotid atherosclerosis
Silveira, A. M. V., McLeod, O., Strawbridge, R. J., Gertow, K., Sennblad, B., Baldassarre, D., Veglia, F., Deleskog, A., Persson, J., Leander, K., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.046 · Cited by 50
Jalbert, E., Crawford, T. Q., D’Antoni, M. L., Keating, S. M., Norris, P. J., Nakamoto, B. K., Seto, T. B., Parikh, N. I., Shikuma, C. M., Ndhlovu, L. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075500 · Cited by 50
Interleukin-6 Signaling, Soluble Glycoprotein 130, and Inflammation in Heart Failure
Askevold, E. T., Gullestad, L. L., Dahl, C. P., Yndestad, A., Ueland, T., & Aukrust, P. (2014) · Current Heart Failure Reports · doi:10.1007/s11897-014-0185-9 · Cited by 49
Wannamethee, S. G., Whincup, P. H., LENNON, L. T., Papacosta, O., & Lowe, G. D. O. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13133 · Cited by 50
Bell, S., Mehta, G., Moore, K. P., & Britton, A. R. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12544 · Cited by 52
Kunimura, A., Ishii, H., Uetani, T., Aoki, T., Harada, K., Hirayama, K., Negishi, Y., Shibata, Y., Sumi, T., Kawashima, K., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.01.008 · Cited by 50
Zuriaga, M. A., Fuster, J. J., Farb, M. G., MacLauchlan, S., Bretón‐Romero, R., Karki, S., Hess, D. T., Apovian, C. M., Hamburg, N. M., Gokce, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17509-5 · Cited by 49
IL-27: a double agent in the IL-6 family
Jones, G. W., Hill, D. G., Figueras, A. C., & Jones, S. A. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13116 · Cited by 48
Cainzos‐Achirica, M., Enjuanes, C., Greenland, P., McEvoy, J. W., Cushman, M., Dardari, Z., Nasir, K., Budoff, M. J., Al-Mallah, M. H., Yeboah, J., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.034 · Cited by 50
Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
Haybar, H., Shokouhian, M., Bagheri, M., Davari, N., & Saki, N. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.010 · Cited by 55
Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure
Askevold, E. T., Nymo, S. H., Ueland, T., Gravning, J. A., Wergeland, R., KJEKSHUS, J. K., Yndestad, A., Cleland, J. G. F., McMurray, J. J. V., Aukrust, P., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.972653 · Cited by 50
Noveck, R. J., Stroes, E. S. G., Flaim, J., Baker, B. F., Hughes, S. G., Graham, M. J., Crooke, R. M., & Ridker, P. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001084 · Cited by 49
All roads lead to IL-6: A central hub of cardiometabolic signaling
Libby, P., & Rocha, V. Z. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.062 · Cited by 49
Advances in the Understanding of Plaque Composition and Treatment Options
Tomey, M. I., Narula, J., & Kovacic, J. C. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.042 · Cited by 49
Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm
Vinciguerra, M., Romiti, S., Fattouch, K., Bellis, A. D., & Greco, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072095 · Cited by 50
Xu, Z., Yang, S., Tan, Y., Zhang, Q., Wang, H., Tao, J., Liu, Q., Wang, Q., Feng, W., Li, Z., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05379-9 · Cited by 64
Inflammation and Coronary Artery Disease: Insights From Genetic Studies
McPherson, R., & Davies, R. W. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.05.014 · Cited by 46
The interleukin-6 pathway and atherosclerosis
Boekholdt, S. M., & Stroes, E. S. G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60361-4 · Cited by 49
Ofstad, A. P., Gullestad, L. L., Orvik, E., Aakhus, S., Endresen, K., Ueland, T., Aukrust, P., Fagerland, M. W., Birkeland, K. I., & Johansen, O. E. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-126 · Cited by 48
The soluble interleukin-6 receptor and related proteins
Rose‐John, S. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.001 · Cited by 51
HECKE, T. V., Jakobsen, L. M. A., Vossen, E., Guéraud, F., Vos, F. D., Pierre, F., Bertram, H. C., & SMET, S. D. (2016) · Food & Function · doi:10.1039/c6fo00462h · Cited by 49
Çolak, Y., Afzal, S., Lange, P., & Nordestgaard, B. G. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty077 · Cited by 50
Abdominal Aortic Aneurysm Genetic Associations: Mostly False? A Systematic Review and Meta-analysis
Bradley, D., Badger, S. A., McFarland, M., & Hughes, A. (2015) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2015.09.006 · Cited by 48
Collaborators, A., van Dongen, J., Jansen, R., Smit, D. J. A., Hottenga, J., Mbarek, H., Willemsen, G. A. H. M., Kluft, C., Penninx, B. W. J. H., Ferreira, M. A. R., et al. (2014) · Behavior Genetics · doi:10.1007/s10519-014-9656-8 · Cited by 45
Novel anti-inflammatory strategies in atherosclerosis
van der Valk, F. M., van Wijk, D. F., & Stroes, E. S. G. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283587543 · Cited by 48
Villani, A. P., Pavel, A. B., Wu, J., Fernandes, M., Maari, C., Proulx, É. S., Jack, C. S., Glickman, J. W., Choi, S., He, H., et al. (2021) · Allergy · doi:10.1111/all.14859 · Cited by 47
Matsuda, T. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00887 · Cited by 49
Niiranen, T., & Vasan, R. S. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1176528 · Cited by 49
Buch, M. H., Mallat, Z., Dweck, M. R., Tarkin, J. M., O’Regan, D. P., Ferreira, V. M., Youngstein, T., & Plein, S. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01149-x · Cited by 50
Pereira, S. M. P., Merkin, S. S., Seeman, T. E., & Power, C. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.016 · Cited by 45
Bretherick, A. D., Canela-Xandri, O., Joshi, P. K., Clark, D. W., Rawlik, K., Boutin, T. S., Zeng, Y., Amador, C., Navarro, P., Rudan, I., et al. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1008785 · Cited by 42
Pol, T., Hijazi, Z., Lindbäck, J., Oldgren, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Lópes, R. D., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab262 · Cited by 45
Genome‐Wide Association Studies
Morris, A. P., & Cardon, L. R. (2019) · Wiley eBooks · doi:10.1002/9781119487845.ch21 · Cited by 45
Ferraz‐Amaro, I., Hernández-Hernández, V., Segura, B. T., Delgado-Frías, E., Macía-Díaz, M., Machado, J. D., & Díaz‐González, F. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0833-4627 · Cited by 45
Benson, M. D., Eisman, A. S., Tahir, U. A., Katz, D. H., Deng, S., Ngo, D., Robbins, J., Hofmann, A., Shi, X. D., Zheng, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.012 · Cited by 46
Coronary Flow Reserve from Mouse to Man—from Mechanistic Understanding to Future Interventions
Gan, L., Wikström, J., & Fritsche‐Danielson, R. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9497-5 · Cited by 44
Interleukin‐6, interleukin‐6 receptor gene variant, small‐vessel disease and incident dementia
Miwa, K., Okazaki, S., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2016) · European Journal of Neurology · doi:10.1111/ene.12921 · Cited by 43
Lee, M. J., Kim, H., Kim, E. H., Bae, S. J., Kim, K. W., Kim, M.-J., & Choe, J. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315054 · Cited by 46
Metadata
- Authors
- ‡
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- ‡
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 379
- Issue
- 9822
- Pages
- 1205-1213
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3316940
- OpenAlex
- W2139957955
- Cited by
- 823
- References
- 47
- Citations by year
- 2026: 48 · 2025: 46 · 2024: 63 · 2023: 46 · 2022: 50 · 2021: 69 · 2020: 73 · 2019: 57 · 2018: 61 · 2017: 60 · 2016: 58 · 2015: 48 · 2014: 72 · 2013: 48 · 2012: 23
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/014)
- Bupa Foundation
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- IL-6 receptor, coronary artery disease, rs2228145, genetic association, inflammation, C-reactive protein, fibrinogen, interleukin-6, chronic inflammation, cardiovascular risk factors, monocytes, gene expression
- MeSH terms
- Coronary Disease, Gene Frequency, Humans, Risk Factors, Genetic Variation, Signal Transduction, Causality, Inflammation Mediators, Receptors, Interleukin-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
